Burlington, Mass.-based Tufts Medicine recorded an operating loss of $31.8 million (-4.2% operating margin) in the first quarter of 2026, down from an operating loss of $28.9 million (-4.1% margin) during the same period last year, according to its Feb. 2 financial report.
The system reported total operating revenue of $760.4 million for the three months ended Dec. 31, up from $710.7 million during the same period last year. Patient service revenue totaled $594.1 million, up from $574 million.
Total operating expenses were $792.2 million in the quarter, up from $739.7 million last year. Salaries, wages and employee benefits totaled $422.2 million, up from $392.8 million. Supplies and other expenses were $224 million, up from $192.2 million.
Tufts Medicine reported a net loss of $35.6 million in the quarter, down from a net loss $26.6 million last year.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
